Companies›Services›Services›Commercial Services & Supplies

JOHNSON PHARMACARE LIMITED

Services › Commercial Services & Supplies
₹0.43
at close · 9 Oct 2026
▼ 0.02 (-4.44%)

Latest filings

  1. Trading window closed from Oct 1 till 48 hours after Q2/H1 FY27 results · Compliance
  2. Q1 FY27 results: Johnson Pharmacare posts Rs 110 lakh loss on nil revenue · Compliance
  3. Company confirms SEBI disclosure rule on share issues not applicable for June quarter · Compliance
All filings ↓
Ask Nexa about JOHNSON PHARMACARE LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

A BSE-listed entity classified in the services sector reported total income of Rs 158.10 lakhs against total expenses of Rs 4,304.49 lakhs in FY26, producing a net loss of Rs 5,573.39 lakhs. Revenue from operations was nil across reported quarters in FY26, and one auditor filing described the entity as an unregistered lending entity. Borrowings stood at Rs 2,140.19 lakhs in the form of inter-corporate deposits, with total assets of Rs 2,203.11 lakhs and negative other equity of Rs 5,456.48 lakhs. The statutory auditor flagged going concern doubts, non-provision of interest on loans, non-compliance with Ind AS, and investments exceeding Section 186 limits. Two directors resigned in April 2026 and were replaced by a father-son pair from Muzaffarpur, Bihar. The company lacks a Chief Financial Officer and an internal auditor, and statutory auditors resigned during the year.

Operating scale
Borrowings (inter-corporate deposits)
Rs 2,140.19 lakhsFY26
Total assets
Rs 2,203.11 lakhsFY26
Total income
Rs 158.10 lakhsFY26
Biggest cost
Finance costs on borrowings (inter-corporate deposits) of Rs 2,140.19 lakhs
Kind of business
Non-operating entity with inter-corporate lending activity; auditor flagged going concern doubts and Ind-AS non-compliance
Where it sits
Listed on BSE under the name Johnson Pharmacare; auditor flagged inability to meet liabilities due within one year
Market Cap
₹25 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-1.0%·
ROCE (5y median)
ROE -1.0% (5y median) · margin —
Leverage
49.18·
Debt / Equity · high
Net debt ₹21 Cr
Revenue FY21→FY26
0.0×▼
Revenue change
₹1 Cr → ₹0 Cr
Moves on a normal day
1.65%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 127 Diversified Commercial Services peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#96/96
ROCE#102/103
ROE#113/113
Debt / Equity#91/91
Profit growth#110/110

Scorecard

Measured from the filed financials, judged against its Diversified Commercial Services peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Erratic profits — up in only 2 of the last 5 years
Negative returns on capital — −1.0% (5-year median)
#102 of 103 in Diversified Commercial Services on the latest reported figures · down from 0.0% in FY21
Carries more debt than its peers — 49.18× equity
higher than 100% of its 91 Diversified Commercial Services peers

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from JOHNSON PHARMACARE LIMITED's filed financials and exchange disclosures

What does JOHNSON PHARMACARE LIMITED do?

JOHNSON PHARMACARE LIMITED is a Commercial Services & Supplies company listed on BSE.

Is JOHNSON PHARMACARE LIMITED profitable?

No. Over the trailing twelve months JOHNSON PHARMACARE LIMITED reported a net loss of ₹56 Cr with no revenue reported.

Does JOHNSON PHARMACARE LIMITED pay a dividend?

Not in the latest reported year — JOHNSON PHARMACARE LIMITED's dividend payout for FY26 was nil.

Is JOHNSON PHARMACARE LIMITED debt-free?

No. It reported borrowings of ₹21 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹21 Cr after cash. Debt stands at 49.18× equity. That is higher than 100% of its 91 Diversified Commercial Services peers.

How much does the JOHNSON PHARMACARE LIMITED share price move in a day?

On a typical session JOHNSON PHARMACARE LIMITED moves 1.65% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track JOHNSON PHARMACARE LIMITED's announcements?

Every NSE and BSE filing by JOHNSON PHARMACARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.